Sections
Medicines: the great hold-up?
-
-
Émission
-
20 February 2019
Légende
Phenomenal margins, treatments billed at more than 80 times their manufacturing cost, general opacity on pricing. Cancer drugs cost Swiss policyholders more than a billion francs in 2018.
